BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Magnocavallo M, Bellasi A, Mariani MV, Fusaro M, Ravera M, Paoletti E, Di Iorio B, Barbera V, Della Rocca DG, Palumbo R, Severino P, Lavalle C, Di Lullo L. Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy. J Clin Med 2020;10:E83. [PMID: 33379379 DOI: 10.3390/jcm10010083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Krisanapan P, Pattharanitima P, Thongprayoon C, Cheungpasitporn W. Recent Advances in Understanding of Cardiovascular Diseases in Patients with Chronic Kidney Disease. JCM 2022;11:4653. [DOI: 10.3390/jcm11164653] [Reference Citation Analysis]
2 Xu Y, Chang AR, Inker LA, Mcadams‐demarco M, Grams ME, Shin J. Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation. JAHA. [DOI: 10.1161/jaha.122.025723] [Reference Citation Analysis]
3 Römer P, Heimes D, Pabst A, Becker P, Thiem DGE, Kämmerer PW. Bleeding disorders in implant dentistry: a narrative review and a treatment guide. Int J Implant Dent 2022;8. [DOI: 10.1186/s40729-022-00418-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Calderon JM, Martinez F, Fernandez A, Sauri I, Diaz J, Uso R, Trillo JL, Redon J, Forner MJ. Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status. Sci Rep 2022;12:6123. [PMID: 35414001 DOI: 10.1038/s41598-022-10164-5] [Reference Citation Analysis]
5 Ito T, Akamatsu K, Hasegawa H, Sakatani Y, Miyamura M, Hoshiga M. Relationship of warfarin versus DOACs with thrombogenic milieu in the left atrium among patients with nonvalvular atrial fibrillation. Echocardiography 2022. [PMID: 35137446 DOI: 10.1111/echo.15319] [Reference Citation Analysis]
6 Chimenti C, Lavalle C, Magnocavallo M, Alfarano M, Mariani MV, Bernardini F, Della Rocca DG, Galardo G, Severino P, Di Lullo L, Miraldi F, Fedele F, Frustaci A. A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy. ESC Heart Fail 2021. [PMID: 34918480 DOI: 10.1002/ehf2.13694] [Reference Citation Analysis]
7 Di Lullo L, Lavalle C, Magnocavallo M, Mariani MV, Della Rocca DG, Severino P, Di Iorio BR, Russo D, Summaria F, Forleo GB, Ronco C, Mancone M, Chimenti C, Miraldi F, Natale A, Bellasi A. New evidence of direct oral anticoagulation therapy on cardiac valve calcifications, renal preservation and inflammatory modulation. Int J Cardiol 2021;345:90-7. [PMID: 34688719 DOI: 10.1016/j.ijcard.2021.10.025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Severino P, D'Amato A, Prosperi S, Fanisio F, Birtolo LI, Costi B, Netti L, Chimenti C, Lavalle C, Maestrini V, Mancone M, Fedele F. Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets. Int J Mol Sci 2021;22:7650. [PMID: 34299270 DOI: 10.3390/ijms22147650] [Reference Citation Analysis]
9 Boriani G, De Caterina R, Manu MC, Souza J, Pecen L, Kirchhof P. Impact of Weight on Clinical Outcomes of Edoxaban Therapy in Atrial Fibrillation Patients Included in the ETNA-AF-Europe Registry. J Clin Med 2021;10:2879. [PMID: 34209595 DOI: 10.3390/jcm10132879] [Reference Citation Analysis]